Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease

[1]  G. Spolverato,et al.  Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease , 2023, Movement disorders : official journal of the Movement Disorder Society.

[2]  S. Rizzo,et al.  Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei , 2023, npj Parkinson's Disease.

[3]  D. Guidolin,et al.  Topography and distribution of adenosine A2A and dopamine D2 receptors in the human Subthalamic Nucleus , 2022, Frontiers in Neuroscience.

[4]  M. Cenci,et al.  Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease , 2022, Neuropharmacology.

[5]  K. Walters,et al.  Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis , 2021, Journal of geriatric psychiatry and neurology.

[6]  E. Bézard,et al.  Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? , 2021, Nature Reviews Neuroscience.

[7]  L. Tremblay,et al.  Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs , 2021, Movement disorders : official journal of the Movement Disorder Society.

[8]  D. Bosco,et al.  Effects of safinamide on REM sleep behavior disorder in Parkinson disease: A randomized, longitudinal, cross-over pilot study , 2021, Journal of Clinical Neuroscience.

[9]  S. Lorenzl,et al.  Access and Attitudes Toward Palliative Care Among Movement Disorders Clinicians , 2021, Movement disorders : official journal of the Movement Disorder Society.

[10]  C. Pariante,et al.  Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence , 2021, Brain, Behavior, and Immunity.

[11]  S. Fereshtehnejad,et al.  Prodromal Parkinson disease subtypes — key to understanding heterogeneity , 2021, Nature Reviews Neurology.

[12]  D. Brooks,et al.  Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. , 2020, Brain : a journal of neurology.

[13]  Sebastian Heinzel,et al.  Update of the MDS research criteria for prodromal Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[14]  S. Fereshtehnejad,et al.  Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study. , 2019, Brain : a journal of neurology.

[15]  A. Berardelli,et al.  Pain in Parkinson's disease: facts and uncertainties , 2018, European journal of neurology.

[16]  R. Marconi,et al.  Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study , 2017, Movement disorders : official journal of the Movement Disorder Society.

[17]  A. Lees,et al.  Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease , 2017, JAMA neurology.

[18]  P. Stanzione,et al.  ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[19]  S. Murayama,et al.  Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders , 2016, Movement disorders : official journal of the Movement Disorder Society.

[20]  Angelo Antonini,et al.  Management of impulse control disorders in Parkinson's disease: Controversies and future approaches , 2015, Movement disorders : official journal of the Movement Disorder Society.

[21]  Murat Emre,et al.  Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[22]  A. Pisani,et al.  The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life , 2012, Journal of Neurology.

[23]  Samay Jain,et al.  Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis , 2012, Neurobiology of Disease.

[24]  Angelo Antonini,et al.  Parkinson's disease: the non-motor issues. , 2011, Parkinsonism & related disorders.

[25]  D. Aarsland,et al.  The Epidemiology of Dementia Associated with Parkinson's Disease , 2010, Brain pathology.

[26]  A. Lang,et al.  Overview of the extranigral aspects of Parkinson disease. , 2009, Archives of neurology.

[27]  M. Hely,et al.  Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years , 2005, Movement disorders : official journal of the Movement Disorder Society.

[28]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[29]  James Parkinson,et al.  An essay on the shaking palsy. 1817. , 2002, The Journal of neuropsychiatry and clinical neurosciences.